Insiders · Profile

THIRD ROCK VENTURES LP

10% owner at CytomX Therapeutics. Filing since 23 Mar 2017. CIK 0001408591

Company
Date
Role
Action
Shares
Amount
Of holding
27 Mar 2017
10% owner
Sold, plan not stated
650,000
$11.70M
11.2%
23 Mar 2017
10% owner
Sold, plan not stated
1,000,000
$17.00M
14.7%
2 decisions on file.